Measuring Lifestyle Medicine in Vietnamese Healthcare: What Outcomes and Quality Indicators Should We Track?
RESEARCH & IMPLEMENTATIONLIFESTYLE MEDICINE IN VIET NAM


Measuring Lifestyle Medicine in Vietnamese Healthcare: What Outcomes and Quality Indicators Should We Track?
Last reviewed: 1 November 2026
A healthcare organization may provide hundreds of Lifestyle Medicine consultations, organize educational sessions and encourage patients to improve their diet, physical activity and sleep. These activities can be valuable, but the number of consultations or participants tells us relatively little about whether care has improved.
Consider a patient receiving support for hypertension. The patient may report eating healthier food and walking more regularly. The clinician may feel that the consultation went well. Yet several questions remain. Has blood pressure improved? Is the patient following an achievable care plan? Has treatment been reviewed when clinically necessary? Are follow-up appointments taking place, and have any safety concerns emerged?
These are questions about the quality and outcomes of care, not simply whether an intervention was delivered.
As Lifestyle Medicine develops in Viet Nam, healthcare organizations will need practical ways to evaluate what their programs achieve. The objective should not be to measure everything, but to measure what helps clinicians and organizations understand whether patients are benefiting, whether care is safe and what needs to improve.
Why measurement matters in Viet Nam
Viet Nam is strengthening prevention, early detection and community-based management of noncommunicable diseases. In September 2026, the World Health Organization reported that the country's expanding hypertension and diabetes management program was supporting the screening of approximately 10 million people annually, with more than 2 million people receiving treatment through the initiative.
These figures describe a national noncommunicable disease program, not a Lifestyle Medicine program. Nevertheless, they illustrate why reliable measurement is increasingly important as healthcare services expand beyond hospital-based treatment into primary care and long-term disease management.
The regulatory environment has also evolved. The Law on Disease Prevention No. 114/2025/QH15, effective from 1 July 2026, establishes a broader legal framework for disease prevention, including noncommunicable diseases and related risk factors. Government Decree No. 165/2026/NĐ-CP and Ministry of Health Circular No. 15/2026/TT-BYT provide further implementing provisions, both effective from the same date.
These developments create a relevant context for evaluating preventive and long-term healthcare services. They do not, however, establish a nationally mandated set of Lifestyle Medicine indicators.
The international Lifestyle Medicine Core Competencies: 2025 Update provides another reason to take measurement seriously. Its clinical competencies address the use of healthcare information systems to support clinical decisions, including tracking screening, test results, referrals and recommended follow-up. They also include quality improvement, collaborative care models and methods for assessing the effectiveness of interventions.
For Vietnamese healthcare organizations considering Lifestyle Medicine programs, measurement should therefore be part of planning from the beginning rather than something added after an intervention has already been introduced.
Measuring activity is not the same as measuring improvement
Healthcare organizations are often good at counting activities. They know how many consultations were completed, how many people attended training and how many educational materials were distributed. These figures can help describe workload and service reach, but they cannot establish whether an intervention improved health.
A hospital might introduce a structured Lifestyle Medicine pathway for patients with hypertension. Over six months, it could report that 500 patients received nutritional counseling. That is useful operational information, but it does not answer whether patients received appropriate clinical follow-up, whether blood pressure outcomes changed or whether the pathway introduced additional problems.
The Institute for Healthcare Improvement distinguishes three complementary types of measures: outcome measures, process measures and balancing measures.
Outcome measures describe what happened to patients or the healthcare system. Process measures examine whether the intended steps of care were performed. Balancing measures help identify whether a change that improved one part of the system created unintended problems elsewhere.
For a hypertension pathway, these might involve blood pressure outcomes, completion of appropriate follow-up and additional clinical workload or medication-related safety concerns.
No single measure can adequately describe the quality of an entire Lifestyle Medicine program. A useful measurement system needs to connect what the organization does with what patients experience and what actually changes.
Measurement should also remain proportionate. Collecting more variables does not automatically produce better evidence. Excessive documentation may increase workload, reduce data completeness and make routine evaluation difficult to sustain.
Measurement for quality improvement is different from research
Healthcare organizations beginning Lifestyle Medicine programs should distinguish routine quality improvement from research.
Research generally seeks to generate knowledge that may apply beyond the immediate setting being studied. Quality improvement primarily seeks to understand whether changes introduced into a particular service are producing the intended improvements.
For example, a hospital implementing a new follow-up process for patients with hypertension may initially need to determine whether eligible patients are identified, appointments occur as planned and clinical results are reviewed appropriately. These questions can be investigated through routine quality-improvement methods without necessarily conducting a randomized clinical trial.
The Institute for Healthcare Improvement encourages organizations to collect enough data to support learning and to test changes through repeated improvement cycles. Measuring a small number of relevant indicators over time is often more useful for this purpose than collecting a large dataset without a clear plan for interpretation.
However, the distinction between research and quality improvement is not always straightforward. A project described as quality improvement may still require institutional review, ethical oversight or other approvals depending on its purpose, design, use of identifiable information and applicable requirements.
Organizations should consider these matters before beginning data collection, particularly when results may be used for research, publication or purposes beyond routine clinical improvement.
Quality-improvement data can reveal whether a process is becoming more reliable, but an observed improvement does not necessarily prove that the Lifestyle Medicine intervention caused it. Patient characteristics, changes in medication, other treatments and wider healthcare developments may also influence outcomes.
This distinction is important when communicating program results. Healthcare organizations should avoid presenting simple before-and-after comparisons as definitive evidence of clinical effectiveness without considering the limitations of their evaluation design.
There is no need for one universal Lifestyle Medicine score
Lifestyle Medicine addresses several health behaviors and many different clinical conditions. A single score combining nutrition, physical activity, sleep, stress management, substance use and social connection may be attractive because it simplifies reporting. However, it can also hide important differences between patients and clinical pathways.
One patient may improve physical activity but continue to have uncontrolled hypertension. Another may achieve meaningful weight loss but experience symptomatic hypotension after changes in body weight and medication requirements. A third may stop smoking while showing little short-term change in laboratory measurements.
These situations should not be reduced to the same composite score without careful consideration of what the score represents.
A more useful starting point is the clinical purpose of the program. A hypertension pathway should focus on outcomes relevant to blood pressure management. A tobacco-cessation program should measure meaningful tobacco-use outcomes. An obesity service should consider cardiometabolic health, functional outcomes and patient experience alongside body weight.
Lifestyle behaviors can then be measured to help explain whether the intervention is influencing the factors it was designed to address.
This approach allows organizations to retain the breadth of Lifestyle Medicine without losing the specificity needed for clinical decision-making.
A proposed measurement structure for Lifestyle Medicine in Viet Nam
The Vietnam Lifestyle Medicine Alliance proposes the following seven domains as a practical educational structure for discussing measurement in healthcare organizations. They are intended to support program planning, implementation and quality improvement.
This is a proposed framework, not a Vietnamese national quality standard, clinical practice guideline, accreditation requirement or mandatory indicator set. The indicators selected by an organization should reflect its clinical purpose, patient population, available resources and applicable professional and regulatory requirements.
1. Clinical outcomes: Are patients getting better?
Clinical outcomes should reflect the disease or health condition being managed. They provide information about whether patients are achieving meaningful improvements, although the interpretation of those changes must consider other treatments and clinical circumstances.
In hypertension care, organizations might monitor blood pressure, changes from baseline and the proportion of eligible patients achieving clinically appropriate treatment targets. In diabetes care, relevant measures may include glycemic control and other cardiometabolic indicators. For an obesity program, outcomes may extend beyond weight to include metabolic health, symptoms, physical function and quality of life.
Clinical outcomes should be selected according to the purpose of the program and the evidence-based guidance relevant to the condition being managed. Targets should not automatically be identical for every patient.
A particularly important consideration is whether the measure reflects a benefit that matters clinically. For example, a modest change in body weight may be accompanied by meaningful improvements in function or metabolic health, while greater weight loss may be concerning if it occurs in a patient at risk of malnutrition.
Similarly, a physical-activity intervention may aim to improve mobility, functional capacity or disease-specific outcomes rather than simply increase exercise duration.
The central question is whether the selected clinical measures represent the improvements the program was designed to achieve.
2. Behavioral outcomes: Are the intended behaviors changing?
Behavioral outcomes help organizations understand whether an intervention is influencing the habits or activities it targets.
Depending on the program, relevant measures may include physical activity, sedentary behavior, dietary patterns, sleep duration or quality, tobacco-use status, alcohol consumption or adherence to agreed behavior-change plans.
These measures can be particularly valuable when clinical outcomes take longer to change. For example, a physical-activity program may demonstrate increasing participation and functional improvement before changes in other health indicators become apparent.
However, organizations should avoid measuring all six Lifestyle Medicine pillars simply because they are part of the discipline. A tobacco-treatment program does not necessarily need a detailed sleep questionnaire, while a sleep-focused intervention may not need extensive dietary assessment.
The measurement method also matters. Self-reported behavior, clinical assessment and wearable-device data may produce different information. Organizations should choose tools that are appropriate to the intended purpose and use them consistently.
Where questionnaires developed internationally are used in Viet Nam, translation alone should not be assumed to establish cultural validity. Their suitability, reliability and validation in the relevant population should be considered.
A behavior measure is most useful when the clinical team understands what it represents, how it is collected and how it will inform care.
3. Patient-reported outcomes: Does care improve what matters to patients?
Clinical measurements do not capture every aspect of health that matters to patients.
A person may achieve better blood pressure control but find the care plan too demanding to maintain. Another may experience meaningful improvement in mobility, energy or daily functioning even when changes in laboratory results are modest.
Patient-reported outcome measures can help capture these experiences. Depending on the program, they may address symptoms, quality of life, physical function, emotional well-being or the impact of a condition on everyday activities.
Other measures, such as confidence in self-management, patient activation or the quality of the therapeutic relationship, may help explain engagement and behavior change. These constructs can complement clinical outcomes but should not replace them.
The World Health Organization's quality-of-life instruments provide examples of internationally developed assessment approaches. A Vietnamese translation of the WHOQOL-BREF is available through WHO resources. However, WHO notes that translations published through its website were not produced by WHO itself and that it does not assume responsibility for their accuracy.
Organizations should therefore confirm whether a particular instrument is suitable, appropriately validated and practical for their population before adopting it.
Patient-reported measures are most valuable when the information influences care. Asking patients about treatment burden or daily functioning is useful only if the clinical team is prepared to respond when problems are identified.
4. Process measures: Is the intended care actually being delivered?
Process measures help healthcare organizations understand whether the care pathway is functioning as intended.
A Lifestyle Medicine program might measure the proportion of eligible patients receiving a documented lifestyle assessment, the proportion with an agreed care plan, completion of clinically indicated referrals or attendance at scheduled follow-up visits.
These measures are especially useful when clinical outcomes are disappointing. If blood pressure control has not improved, the problem may not be the nutritional intervention itself. Perhaps patients are not being assessed consistently, referrals are not completed or follow-up takes place too late.
Process measurement can help identify where the pathway is failing and whether a particular step needs to be redesigned.
The definition of each measure is important. A referral that has been issued is not necessarily a referral that has resulted in care. Similarly, a follow-up appointment that has been scheduled is not the same as one that has been completed.
For a healthcare organization, distinguishing these events may reveal problems that would otherwise remain hidden in routine activity reports.
Where feasible, process measures should be integrated into existing clinical records and quality-management systems instead of requiring staff to maintain separate datasets that are difficult to reconcile.
5. Safety and balancing measures: Is improvement creating other problems?
Lifestyle interventions are sometimes assumed to carry little clinical risk. Many can be delivered safely, but changes in nutrition, physical activity, body weight and other behaviors may influence clinical parameters, particularly in people receiving ongoing treatment.
For example, improved glycemic control associated with dietary or activity changes may require clinical review in a patient using glucose-lowering medication. Changes in blood pressure may require assessment of antihypertensive treatment when symptoms develop. A new exercise program may need adjustment if a patient experiences injury, dizziness or worsening symptoms.
The relevant safety indicators should be identified according to the clinical pathway. They may include symptomatic hypoglycemia, hypotension, falls, injury, clinically concerning weight loss, worsening symptoms or other adverse events.
Balancing measures address a related but distinct question: whether improvements in one area create difficulties elsewhere.
A program may increase follow-up attendance but place unsustainable demands on nursing staff. Digital monitoring may improve access for some patients while excluding others who have limited internet access or digital skills. A group-based education program may reduce the resources needed per session but prove difficult for people who work irregular hours.
These consequences should be recognized as part of the evaluation rather than treated as unrelated operational issues.
A program should not be considered successful solely because its primary outcome improved while important safety concerns or unintended burdens went unrecognized.
6. Equity: Who benefits, and who may be left behind?
Average results can conceal differences between population groups.
A Lifestyle Medicine program may demonstrate strong improvements among participants who have stable employment, adequate resources and flexible schedules. Yet people with greater health needs may be less likely to enroll, attend appointments or remain in the program.
If an organization reports only the outcomes of people who completed the intervention, it may overestimate how well the program serves its intended population.
The 2025 Lifestyle Medicine Core Competencies introduced an additional competency concerning the application of Lifestyle Medicine within the context of social determinants of health to improve outcomes and health equity. This provides a strong reason to consider who can access and benefit from interventions.
In Viet Nam, relevant barriers may include travel distance, working hours, financial constraints, disability, caregiving responsibilities, language or digital access. Their importance will differ by location, patient population and service model.
Organizations may therefore consider examining participation, follow-up, discontinuation and clinical outcomes across relevant population groups when appropriate.
However, equity measurement should not become an excuse to collect unnecessary personal information. Data should have a clear purpose, be obtained and processed lawfully, and be protected according to applicable requirements. Small-group reporting should also avoid exposing identifiable information.
The purpose of examining differences is to identify where care needs to improve, not to label patients or make assumptions about their willingness to change.
7. Implementation and sustainability: Can the program work in routine care?
A program may produce encouraging outcomes during a small pilot but prove difficult to maintain when introduced across a larger healthcare organization.
Implementation science provides a useful perspective on this challenge. Proctor and colleagues identified eight implementation outcomes: acceptability, adoption, appropriateness, feasibility, fidelity, implementation cost, penetration and sustainability.
For a Vietnamese hospital or clinic, these concepts translate into practical questions. Do healthcare professionals use the intervention? Do patients consider it acceptable? Does it fit the clinical setting? Can it be delivered with available staff, equipment and time? Are its essential components being delivered as intended?
Organizations also need to understand the resources required to maintain the program. These may include professional training, coordination, information systems, documentation, clinical supervision and referral arrangements.
Implementation costs should be measured realistically rather than assuming that a program will reduce expenditure simply because it uses lifestyle interventions. Any claim of financial savings or cost-effectiveness requires an appropriate economic evaluation that considers relevant costs and outcomes.
Sustainability matters because a successful pilot is not necessarily a sustainable service. A program should be evaluated not only when staff are enthusiastic and additional resources are available, but also when it becomes part of routine operations.
How many indicators does a pilot really need?
A healthcare organization does not need a large dashboard to begin measuring Lifestyle Medicine.
The Institute for Healthcare Improvement commonly recommends using a small family of measures, often around four to ten, covering different aspects of the system. The exact number should depend on the intervention and the decisions the data are intended to support.
A practical pilot may begin with one or two clinically meaningful outcome measures, a behavioral measure linked to the intervention, selected measures of whether the care pathway is being delivered and at least one relevant safety or balancing measure.
Patient-reported outcomes, equity and implementation feasibility should also be considered, although these do not necessarily require a separate indicator for every domain at every stage.
Consider a hypothetical primary-care hypertension pilot. Its initial measurement set could include change in systolic blood pressure, the proportion of eligible patients completing follow-up within a defined period, documented lifestyle assessment, patient-reported feasibility of the care plan, clinically relevant safety events and the resources required to deliver follow-up.
This is an illustrative set, not a recommended national dashboard. Each measure would still need an appropriate definition, and the organization would need to decide whether additional measures are necessary for its patient population.
The purpose is to collect information that can guide decisions rather than to maximize the number of reported indicators.
Every indicator needs a clear definition
A measurement system becomes difficult to interpret when different people understand the same indicator differently.
Take the phrase "blood pressure control." Does it refer to the most recent recorded blood pressure, an average of repeated measurements or a specified treatment target? Which patients are included? Are targets adjusted for relevant clinical circumstances, and how are missing measurements handled?
These details affect how results should be interpreted.
The same principle applies to follow-up. A clinic reporting 80% follow-up completion needs to define which patients were eligible, what counted as a completed follow-up and the period during which it should have occurred.
For measures reported as proportions, the numerator and denominator should be specified. The data source, measurement interval and person responsible for collection should also be clear.
Organizations should consider the quality of the underlying information before using an indicator to compare teams, facilities or periods. Small sample sizes, incomplete records and differences in patient characteristics can make apparent changes misleading.
Clinical targets should reflect applicable evidence-based guidance and the characteristics of the population being served. An international benchmark should not automatically be treated as an appropriate performance target for every Vietnamese setting.
Good measurement begins with clear definitions, reliable data and a shared understanding of what the results can and cannot tell us.
Looking at trends is often more useful than comparing two numbers
A baseline and a final measurement may show whether a result changed, but they can miss important developments during implementation.
A clinic might see follow-up attendance improve during the first three months before declining as patient numbers increase. A hypertension program may initially demonstrate better blood pressure control but later reach a plateau. Another service may maintain clinical outcomes while gradually losing participants who find the appointment schedule difficult.
These patterns are useful for improvement because they identify when problems emerge.
The Institute for Healthcare Improvement emphasizes displaying data over time, including through run charts and other appropriate methods, to help teams distinguish variation from potentially meaningful changes.
This approach also supports the Plan-Do-Study-Act method referenced in the Lifestyle Medicine Core Competencies. Teams can introduce a change, observe what happens, consider the findings and make adjustments before evaluating the results again.
However, an improving trend does not automatically establish that a particular intervention caused the improvement. Changes in case mix, medications, staffing, referral systems or other aspects of care may contribute.
Trend data are especially valuable for operational learning. Stronger causal claims about clinical effectiveness may require more rigorous comparative evaluation.
Measurement should support both purposes without confusing them.
Good measurement should support clinical judgment
A dashboard cannot replace an appropriate clinical assessment.
A reduction in body weight may be beneficial for one patient and concerning for another. Increased physical activity may improve function but may also require adjustment according to symptoms, disability or clinical risk. Lower blood pressure may indicate better control, yet symptomatic hypotension may require medical review.
These examples show why indicators need to be interpreted in context.
Clinical teams should consider what the data mean for individual patients and whether the measurements are aligned with the care plan. Automated thresholds can support review, but they should not be treated as independent clinical decisions.
This is particularly important when digital tools or remote monitoring systems are involved. A wearable device may collect information more frequently than a conventional assessment, but greater data volume does not necessarily mean greater clinical accuracy or usefulness.
Organizations should define which findings require professional review, who is responsible for responding and how clinically important concerns are escalated.
Measurement should make care more reliable without turning person-centered treatment into a process driven solely by numerical targets.
Health data governance is part of quality measurement
Lifestyle Medicine programs may collect blood pressure, laboratory results, weight, dietary information, physical activity, sleep data, mental health information and patient-reported outcomes. Some may also use mobile applications, wearable devices or remote monitoring platforms.
These activities create responsibilities concerning the collection, processing, access, storage, sharing and protection of information.
In Viet Nam, relevant legislation includes Government Decree No. 102/2025/NĐ-CP on health data management, effective from 1 July 2025, and the Law on Personal Data Protection No. 91/2025/QH15, effective from 1 January 2026.
Government Decree No. 356/2025/NĐ-CP, also effective from 1 January 2026, provides detailed provisions and implementation measures for the Personal Data Protection Law. Government Decree No. 330/2026/NĐ-CP, effective from 19 August 2026, establishes administrative penalties for violations in cybersecurity and personal-data protection.
These instruments form part of the legal environment that organizations must consider. Their application depends on the type of data, processing activities, organizational responsibilities and other relevant circumstances.
A healthcare organization should understand why each category of information is required, what lawful basis applies to its processing, who may access it, how long it should be retained and how it will be protected. Appropriate safeguards are especially important when identifiable health information is processed through third-party or cloud-based platforms.
Consent and other applicable legal grounds for data processing should be considered according to the relevant provisions rather than assuming that a single consent form is sufficient for every purpose.
Organizations should also distinguish information required for clinical care from additional data collected for research, service evaluation, education or publication. Different purposes may require different governance arrangements.
Where aggregate or de-identified information can meet the intended measurement purpose, unnecessary exposure of identifiable personal data should be avoided.
Good measurement is not simply about collecting reliable information. It is also about using that information responsibly.
Measurement must remain within Vietnamese clinical governance
Lifestyle Medicine may involve general health education, behavior-change support, clinical assessment or medical treatment. These activities do not necessarily have the same legal or professional requirements.
Where a program involves medical examination and treatment, the applicable framework includes Viet Nam's Law on Medical Examination and Treatment, reflected in Consolidated Document No. 26/VBHN-VPQH dated 26 February 2026, and Government Decree No. 96/2023/NĐ-CP.
Ministry of Health Circular No. 32/2023/TT-BYT also remains relevant, subject to its subsequent amendments. These include Circular No. 25/2025/TT-BYT concerning certain documentation provisions and Circular No. 25/2026/TT-BYT, effective from 15 August 2026, which amended several Ministry of Health circulars, including Circular No. 32/2023/TT-BYT.
These regulations matter when organizations introduce new clinical pathways or assign responsibilities for assessment, treatment and follow-up.
An indicator framework does not grant professional authority. The use of a health coach, educator, exercise professional, nutrition professional or digital platform does not independently authorize diagnosis, prescribing or other regulated clinical activities.
Similarly, the publication of a proposed VLMA measurement structure does not make it an official Vietnamese standard or an accreditation requirement.
The appropriate approach is to integrate measurement into the organization's existing clinical governance arrangements, with clear responsibilities for clinical decisions, professional oversight, referral and escalation.
Common measurement mistakes to avoid
One of the most common mistakes is measuring what is easy rather than what matters. Counting consultations, educational sessions and downloads may be straightforward, but these activities cannot establish that patient outcomes improved.
Another mistake is relying on a single outcome. Weight alone cannot describe the quality of obesity care. Glycemic control alone cannot capture every aspect of diabetes management. Patient satisfaction, while important, cannot independently demonstrate clinical effectiveness.
Organizations may also collect excessive information without establishing how it will be used. Large datasets can become difficult to maintain, particularly when documentation is fragmented across different systems.
A further concern is excluding patients who discontinue a program or miss appointments from the reported results. Doing so may make an intervention appear more successful than it is. Participation, attrition and missing information need to be understood and reported appropriately.
It is also important not to equate patient behavior with personal motivation alone. People may struggle to follow a care plan because of employment demands, financial constraints, disability, family responsibilities, limited access to suitable food or other barriers.
A measurement system should help healthcare teams understand these circumstances and improve the care they provide, rather than become a tool for blaming patients.
Finally, organizations should be cautious about comparing performance across facilities without considering differences in case mix, resources, clinical responsibilities and data quality.
The purpose of quality measurement is to support better decisions, not simply to produce favorable statistics.
A practical starting point for Vietnamese healthcare organizations
For a hospital, clinic or primary-care service introducing Lifestyle Medicine, the most practical starting point is to identify one clearly defined clinical problem.
The organization should describe the population it intends to serve, the intervention it plans to deliver and the outcomes it hopes to improve. It should then select a small number of meaningful measures connected to that purpose.
Before implementation, the team needs to establish how the measures will be defined and collected, what the baseline performance looks like and who will review the information.
Once the program begins, the data should be reviewed regularly with the people responsible for delivering care. Patients and staff can also help explain findings that are not evident from numerical results alone.
For example, low follow-up attendance may reflect a scheduling problem rather than a lack of patient motivation. Poor completion of a referral may indicate limited service availability or difficulties with communication between facilities. Unexpected safety events may suggest that clinical review arrangements need to be strengthened.
The team can use these findings to make targeted changes, assess their effects and refine the program.
Over time, indicators that do not support meaningful decisions may be removed, while new measures can be introduced when the program develops or its clinical priorities change.
A useful measurement system should evolve with the service. It should not require a healthcare organization to maintain the same dashboard indefinitely when the information no longer answers its most important questions.
From delivering Lifestyle Medicine to demonstrating meaningful benefit
As Lifestyle Medicine develops internationally, its credibility in healthcare will increasingly depend on more than the number of people reached or the appeal of its underlying principles.
Healthcare organizations need to understand whether interventions produce meaningful clinical benefits, whether patients can participate and remain engaged, whether care is safe and equitable, and whether services can operate reliably over time.
For Viet Nam, this is especially relevant as the healthcare system strengthens disease prevention, primary care and community-based management of chronic conditions.
The country does not need to adopt a single international measurement framework without considering its own clinical settings, resources and population needs. Nor should every organization be expected to build an extensive measurement system before introducing a modest quality-improvement initiative.
A more practical approach is to begin with clearly defined goals, a small set of relevant measures, reliable data collection and regular review. The information should then be used to improve clinical decisions, care processes and patient experience.
The central question is not how many Lifestyle Medicine activities an organization has delivered. It is whether those activities have helped patients achieve meaningful benefits, whether care has remained safe, and whether the approach can be sustained in the healthcare system.
A credible Lifestyle Medicine program should be able to explain what it does, whom it serves, what it measures and what it has learned. Just as importantly, it should be prepared to change when the evidence and results show that something could be done better.
References and Further Reading
Rea BL, Cheema S, Lanza S, Makinde MT, Matthews S, Palma M, Szentgyörgyi B, Karlsen MC. Lifestyle Medicine Core Competencies: 2025 Update. American Journal of Lifestyle Medicine. 2026;20(3):443–451. doi:10.1177/15598276251379821.
World Health Organization Viet Nam. Strengthened grassroots health care brings NCD services to 10 million in Viet Nam. 8 September 2026.
National Assembly of Viet Nam. Law on Disease Prevention No. 114/2025/QH15. Adopted 10 December 2025; effective 1 July 2026.
Government of Viet Nam. Decree No. 165/2026/NĐ-CP detailing and guiding the implementation of certain provisions of the Law on Disease Prevention. 15 May 2026; effective 1 July 2026.
Ministry of Health of Viet Nam. Circular No. 15/2026/TT-BYT detailing certain provisions of the Law on Disease Prevention. 17 May 2026; effective 1 July 2026.
Institute for Healthcare Improvement. How to Improve: Model for Improvement – Establishing Measures. Professional guidance resource.
World Health Organization. WHO clinical treatment guideline for tobacco cessation in adults. Geneva: World Health Organization; 2024.
World Health Organization. WHOQOL: Measuring Quality of Life and WHOQOL-BREF Translation Resources.
Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, Griffey R, Hensley M. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Administration and Policy in Mental Health and Mental Health Services Research. 2011;38(2):65–76. doi:10.1007/s10488-010-0319-7.
Government of Viet Nam. Decree No. 102/2025/NĐ-CP on Health Data Management. 13 May 2025; effective 1 July 2025.
National Assembly of Viet Nam. Law on Personal Data Protection No. 91/2025/QH15. 26 June 2025; effective 1 January 2026.
Government of Viet Nam. Decree No. 356/2025/NĐ-CP detailing certain provisions and implementation measures of the Law on Personal Data Protection. 31 December 2025; effective 1 January 2026.
Government of Viet Nam. Decree No. 330/2026/NĐ-CP on administrative penalties for violations in cybersecurity and personal-data protection. 19 August 2026; effective 19 August 2026.
Office of the National Assembly of Viet Nam. Consolidated Document No. 26/VBHN-VPQH: Law on Medical Examination and Treatment. 26 February 2026.
Government of Viet Nam. Decree No. 96/2023/NĐ-CP detailing certain provisions of the Law on Medical Examination and Treatment. 30 December 2023; effective 1 January 2024.
Ministry of Health of Viet Nam. Circular No. 32/2023/TT-BYT detailing certain provisions of the Law on Medical Examination and Treatment. 31 December 2023, as subsequently amended.
Ministry of Health of Viet Nam. Circular No. 25/2025/TT-BYT concerning implementation of social insurance, occupational safety and health legislation and certain provisions of the Law on Medical Examination and Treatment. 30 June 2025.
Ministry of Health of Viet Nam. Circular No. 25/2026/TT-BYT amending and supplementing provisions of several Ministry of Health circulars, including Circular No. 32/2023/TT-BYT. 30 June 2026; effective 15 August 2026.
Implementation and measurement note
This article is intended for professional education, quality improvement and organizational planning. The proposed measurement structure and example indicators are not Vietnamese national quality indicators, mandatory clinical practice guidelines, accreditation standards or regulatory requirements. Healthcare organizations should select and define indicators according to the clinical purpose and population being served, applicable evidence-based guidance, authorized professional scopes of practice, institutional governance, relevant ethical requirements and current Vietnamese regulations concerning health information and personal-data protection.
Vietnam Lifestyle Medicine Alliance
Evidence-Based Lifestyle Medicine for Viet Nam.
Contact
contact@vlma.org
Saigon Paragon Building, No. 3 Nguyen Luong Bang Street, Tan My Ward, HCMC
+84 909 228 476
+84 84 9999 911
© 2025 - 2026. Vietnam Lifestyle Medicine Alliance. All rights reserved.
A physician-led professional platform advancing Lifestyle Medicine through education, collaboration, research, and responsible implementation.
VLMA is operated by Vietnam Lifestyle Medicine Alliance Company Limited, Enterprise Registration Number 0318902666.
VLMA is a Sister Organization of the Lifestyle Medicine Global Alliance and a Member Organization of the Planetary Health Alliance.
VLMA is not a medical service provider and does not issue medical licenses or IBLM certification.
